Format

Send to

Choose Destination
Epigenomics. 2017 Mar;9(3):291-311. doi: 10.2217/epi-2016-0163. Epub 2017 Feb 17.

Epigenetics studies of fetal alcohol spectrum disorder: where are we now?

Author information

1
Department of Medical Genetics, Centre for Molecular Medicine & Therapeutics, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
2
Department of Cellular & Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
3
Human Early Learning Partnership, University of British Columbia, Vancouver, British Columbia, Canada.

Abstract

Adverse in utero events can alter the development and function of numerous physiological systems, giving rise to lasting neurodevelopmental deficits. In particular, data have shown that prenatal alcohol exposure can reprogram neurobiological systems, altering developmental trajectories and resulting in increased vulnerability to adverse neurobiological, behavioral and health outcomes. Increasing evidence suggests that epigenetic mechanisms are potential mediators for the reprogramming of neurobiological systems, as they may provide a link between the genome, environmental conditions and neurodevelopmental outcomes. This review outlines the current state of epigenetic research in fetal alcohol spectrum disorder, highlighting the role of epigenetic mechanisms in the reprogramming of neurobiological systems by alcohol and as potential diagnostic tools for fetal alcohol spectrum disorder. We also present an assessment of the current limitations in studies of prenatal alcohol exposure, and highlight the future steps needed in the field.

KEYWORDS:

FASD; animal models; clinical cohorts; development; epigenetics; fetal programming; prenatal alcohol exposure

PMID:
28234026
PMCID:
PMC5549650
DOI:
10.2217/epi-2016-0163
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center